Mengqing Zhang

机构：Hebei Medical University, Peking University, Guangzhou Women and Children Medical Center, Peking University People's Hospital, Guangzhou Medical University · ORCID：0009-0006-0104-0890

发表论文 13 篇 · 总被引 118 次 · h-index 6

代表论文

• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
• Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice (2025 · International Immunopharmacology · 被引 18)
• Videofluoroscopic Swallowing Study Features and Resting-State Functional MRI Brain Activity for Assessing Swallowing Differences in Patients with Mild Cognitive Impairment and Risk of Dysphagia (2022 · Dysphagia · 被引 18)
• One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA (2024 · Diabetes Obesity and Metabolism · 被引 12)
• Dapagliflozin Treatment and Cardiovascular Outcome in RBP4/TTRVal30Met (Transthyretin Cardiac Amyloidosis) Mice (2023 · ESC Heart Failure · 被引 8)
• Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways (2024 · Pharmaceuticals · 被引 7)